Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
72 /100
HIGH RISK
Score updated Oct 13, 2026

BRTX — BioRestorative Therapies, Inc. Dilution Risk Tracker

Track BRTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BRTX — Get alerts when the score changes →

As of October 13, 2026, BioRestorative Therapies, Inc. (BRTX) has a DilutionWatch DilutionScore of 72/100, rated HIGH dilution risk. BioRestorative Therapies, Inc. has a market capitalization of $44.59M, 25.48M shares outstanding, 10 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $10.00M, ATM program capacity of $5.44M, 4.50M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
85
📊 Float Risk
12
⚠️ Warrant Exposure
50
🔄 Convertible Debt
15

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 62%
💰 Capital Raise model 73%
• Low cash runway: 4 months remaining
• Active shelf registration ($10M, 22% of market cap)
🔄 Reverse Split model est. 70%
• 50-day avg $0.25 below $1 exchange minimum
• Only 4 months cash — financial pressure
📜 Warrant Exercise model 25%
• Significant warrants: 18% of shares outstanding
🔔 Track BRTX — Get forecast alerts →

Market Data

Market Cap$44.59M
Shares Outstanding25.48M
Float24.18M
Cash$3.59M
Debt$153.7K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore72/100DilutionWatch score record
Shares Outstanding25.48MVerified float table or market cache
Public Float24.18MVerified float table or market cache
Market Cap$44.59MMarket data cache
Cash Runway3.8 monthsDilutionWatch score inputs
Shelf Capacity$10.00MSEC-derived dilution fields
ATM Capacity$5.44MSEC-derived dilution fields
Outstanding Warrants4.50MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 424B3 1, 8-K 1, EFFECT 2, S-1/A 1, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

10 institutional holders · 677.1K shares
#1 Citadel Advisors Llc 238.6K shares
#2 Geode Capital Management, LLC 223.1K shares
#3 UBS Group AG 99.8K shares
+ 7 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest13.2K
Days to Cover1.0
% of Float0.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-26
xbrl XBRL CONVERTIBLE 2023-03-27
424B3 ATM 2026-04-30
EFFECT EFFECT 2026-04-28
8-K 8K EVENT 2026-02-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual BRTX Dilution Snapshot

BioRestorative Therapies, Inc. (BRTX) has a DilutionScore of 72/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

BRTX's DilutionScore is currently 72/100 (High risk), with 3 score changes tracked over 89 days. The score deteriorated from 77/100 (Critical risk).

Period Score Risk Level Duration
Oct 08 – Oct 13, 202672/100HIGH6 days
Aug 22 – Oct 07, 202677/100CRITICAL47 days
Aug 14 – Aug 21, 202689/100CRITICAL7 days
Jul 16 – Aug 13, 202677/100CRITICAL29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track BRTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment BRTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking BRTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BRTX
BRTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.